Status:
RECRUITING
Acceptability, Gastrointestinal Tolerance, Compliance and Palatability Study.
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Paediatrics
Eligibility:
All Genders
1-16 years
Phase:
NA
Brief Summary
Acceptability, compliance and palatability study.
Detailed Description
Acceptability (including gastrointestinal tolerance, compliance and palatability) of a paediatric oral nutritional supplement containing food blends.
Eligibility Criteria
Inclusion
- Patients from 1-15 years requiring 1 or more oral nutritional supplement to replace current oral nutritional supplement as part of their dietary management for disease related malnutrition.
- Patients well-established and stable on current nutritional support regimen.
- Willingly given, written, informed consent from patient/caregiver.
Exclusion
- Unsafe swallow
- Inability to comply with the study protocol, in the opinion of the investigator.
- Under 1 years of age
- Patients on total parenteral nutrition
- Known food allergies, including any allergies to the ingredients
- Patients with Chronic Kidney Disease (CKD) stage 3b (G3b), stage 4 (G4), stage 5 (G5) or hepatic impairment.
- Participation in another interventional study within 2 weeks of this study.
- Patients with known or suspected ileus or mechanical bowel obstruction
Key Trial Info
Start Date :
April 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2026
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT07210658
Start Date
April 14 2025
End Date
May 15 2026
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dietetics
Nottingham, United Kingdom